Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Investor World Review.
Press releases published on May 23, 2025
Brompton Split Banc Corp. Renews At-the-Market Equity Program
GlobeNewswire
·
May 23, 2025
Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, May 22, 2025 (GLOBE NEWSWIRE) -- (TSX: SBC, SBC.PR.A) Brompton Split Banc Corp. (the “Fund”) is pleased to announce it has renewed its at-the-market equity …
ADTRAN ALERT: Bragar Eagel & Squire, P.C. is Investigating ADTRAN Holdings, Inc. on Behalf of ADTRAN Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
May 23, 2025
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …
SEMLER ALERT: Bragar Eagel & Squire, P.C. is Investigating Semler Scientific Inc. on Behalf of Semler Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
May 23, 2025
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …
APPLE ALERT: Bragar Eagel & Squire, P.C. is Investigating Apple Inc. on Behalf of Apple Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
May 23, 2025
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …
Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock
GlobeNewswire
·
May 23, 2025
SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced the pricing of its previously announced underwritten public offering of …
Algernon Closes NoBrainer Imaging Centers, Inc. Acquisition
GlobeNewswire
·
May 23, 2025
VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare and clinical stage drug development company, is pleased to announce …
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting
GlobeNewswire
·
May 23, 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new data from several studies of compounds discovered by HUTCHMED including savolitinib, …